M. R. Boyd

10.4k total citations · 1 hit paper
18 papers, 9.3k citations indexed

About

M. R. Boyd is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, M. R. Boyd has authored 18 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in M. R. Boyd's work include Marine Sponges and Natural Products (3 papers), Influenza Virus Research Studies (2 papers) and Medical Imaging Techniques and Applications (2 papers). M. R. Boyd is often cited by papers focused on Marine Sponges and Natural Products (3 papers), Influenza Virus Research Studies (2 papers) and Medical Imaging Techniques and Applications (2 papers). M. R. Boyd collaborates with scholars based in United States, Norway and India. M. R. Boyd's co-authors include Heidi R. Bokesch, David T. Vistica, jeannette mcmahon, Anne Monks, Dominic A. Scudiero, Philip Skehan, James T. Warren, Ritsa Storeng, Susan Kenney and George R. Pettit and has published in prestigious journals such as The Lancet, JNCI Journal of the National Cancer Institute and Brain Research.

In The Last Decade

M. R. Boyd

18 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

1990 8.8k citations Philip Skehan, Ritsa Storeng et al. JNCI Journal of the National Cancer Institute profile →

Peers

M. R. Boyd

ONCOL

PHARM

jeannette mcmahon United States

Susan Kenney United States

Ritsa Storeng Norway

Philip Skehan United States

David T. Vistica United States

Heidi R. Bokesch United States

Mansukh C. Wani United States

HIROSHI NAGANAWA Japan

Sang Kook Lee South Korea

MASA HAMADA Japan

jeannette mcmahon United States

M. R. Boyd

4.4k ×1.0

3.1k ×0.9

1.8k ×1.0

ONCOL

1.2k ×0.9

PHARM

1.1k ×1.0

Citations per year, relative to M. R. Boyd M. R. Boyd (= 1×) peers jeannette mcmahon

Countries citing papers authored by M. R. Boyd

Since Specialization

Citations

This map shows the geographic impact of M. R. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. R. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. R. Boyd more than expected).

Fields of papers citing papers by M. R. Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. R. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. R. Boyd. The network helps show where M. R. Boyd may publish in the future.

Co-authorship network of co-authors of M. R. Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of M. R. Boyd. A scholar is included among the top collaborators of M. R. Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. R. Boyd. M. R. Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

O’Keefe, Barry R., John A. Beutler, John H. Cardellina, et al.. (1997). Isolation and Characterization of Niphatevirin, a Human‐Immunodeficiency‐Virus‐Inhibitory Glycoprotein from the Marine Sponge Niphates Erecta. European Journal of Biochemistry. 245(1). 47–53. 26 indexed citations

Ravindranath, V, et al.. (1997). Histological, histochemical and autoradiographic evidence of in vitro neurotoxic effects of the novel antitumor agent, 9-methoxy-N2-methylellipticinium acetate.. PubMed. 18(1). 89–95. 1 indexed citations

Fodstad, Øystein, et al.. (1996). Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts.. PubMed. 1(2). 119–25. 24 indexed citations

Bhagwat, Shripad V., et al.. (1995). Flavin-containing monooxygenase mediated metabolism of psychoactive drugs by human brain microsomes. Brain Research. 672(1-2). 276–280. 31 indexed citations

Erickson, Karen L., John A. Beutler, John H. Cardellina, et al.. (1995). A Novel Phorbol Ester from Excoecaria agallocha. Journal of Natural Products. 58(5). 769–772. 62 indexed citations

Rashid, Mohammad Mamun Ur, et al.. (1995). Mycalolides D and E, New Cytotoxic Macrolides from a Collection of the Stony Coral Tubastrea faulkneri. Journal of Natural Products. 58(7). 1120–1125. 40 indexed citations

Rowinsky, Eric K., Dennis A. Noe, David S. Ettinger, et al.. (1994). Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: Hepatotoxicity is dose limiting in humans. Lung Cancer. 10(5-6). 424–424. 41 indexed citations

Pettit, George R., Ralph A. Backhaus, M. R. Boyd, & Alan W. Meerow. (1993). Antineoplastic Agents, 256. Cell Growth Inhibitory Isocarbostyrils from Hymenocallis. Journal of Natural Products. 56(10). 1682–1687. 119 indexed citations

Cardellina, John H., Murray H. G. Munro, Richard W. Fuller, et al.. (1993). A Chemical Screening Strategy for the Dereplication and Prioritization of HIV-Inhibitory Aqueous Natural Products Extracts. Journal of Natural Products. 56(7). 1123–1129. 70 indexed citations

10.

Boyd, M. R., et al.. (1991). Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran. Biochemical Pharmacology. 41(9). 1311–1318. 16 indexed citations

11.

Skehan, Philip, Ritsa Storeng, Dominic A. Scudiero, et al.. (1990). New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. JNCI Journal of the National Cancer Institute. 82(13). 1107–1112. 8784 indexed citations breakdown →

12.

Fodstad, Øystein, Inge Kjønniksen, Steinar Aamdal, et al.. (1988). Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.. PubMed. 48(15). 4382–8. 78 indexed citations

13.

Smith, Adaline C., et al.. (1987). Preclinical toxicology studies of 4-ipomeanol: a novel candidate for clinical evaluation in lung cancer.. PubMed. 71(12). 1157–64. 9 indexed citations

14.

Boyd, M. R.. (1984). Metabolic activation and lung toxicity: a basis for cell-selective pulmonary damage by foreign chemicals.. Environmental Health Perspectives. 55. 47–51. 35 indexed citations

15.

Jones, Richard A., et al.. (1979). Potential clinical applications of a new method for quantitation of plasma levels of 5-fluorouracil and 5-fluorodeoxyuridine.. PubMed. 66(1). 75–8. 5 indexed citations

16.

Buckpitt, Alan R., et al.. (1978). Assay of 5-fluorouracil (FU) and 5-fluorodeoxyuridine (FUdR) in plasma at the low nanogram level using high pressure liquid chromatography (HPLC). 1 indexed citations

17.

Boyd, M. R. & Malcolm F. Beeson. (1975). Animal models for evaluation of compounds against influenza viruses. Journal of Antimicrobial Chemotherapy. 1(suppl 4). 43–47. 6 indexed citations

18.

Boyd, M. R., et al.. (1962). EFFECT OF AN INFLUENZA EPIDEMIC ON A CITY POPULATION. The Lancet. 279(7220). 96–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact